TF
TECH icon

Tompkins Financial’s Bio-Techne TECH Stock Holding History

Tompkins Financial’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-200
Closed -$8K – 435
2018
Q1 		$8K Buy
+200
New +$7.07K ﹤0.01% 372
2016
Q3 		– Sell
-60
Closed -$2K – 483
2016
Q2 		$2K Buy
+60
New +$1.54K ﹤0.01% 504
2013
Q3 		– Sell
-1,540
Closed -$27K – 490
2013
Q2 		$27K Buy
+1,540
New +$25.6K 0.01% 320

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Tompkins Financial's TECH Position: Q2 2018 in Review

Tompkins Financial sold out of Bio-Techne (TECH) in Q2 2018, closing a stake of 200 shares — an estimated $8K sold.

Tompkins Financial first reported a position in TECH in Q2 2013 and held it in 3 quarters. The position peaked at $27K in Q2 2013. 342 funds tracked by Wall St. Rank hold TECH as of Q2 2018.

  • Tompkins Financial reported no remaining Bio-Techne position as of Q2 2018 after selling out during the quarter.
  • Tompkins Financial sold 200 Bio-Techne shares in Q2 2018, an estimated $8K.
  • Tompkins Financial first reported a position in Bio-Techne in Q2 2013 and held it in 3 quarters.
  • Tompkins Financial's Bio-Techne position peaked at $27K in Q2 2013.
  • 342 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2018.

Based on Tompkins Financial's 13F filing for Q2 2018, filed 18 Jul 2018.